Vishnoi, Monika https://orcid.org/0000-0002-3934-7285
Dereli, Zeynep
Yin, Zheng
Kong, Elisabeth K.
Kinali, Meric
Thapa, Kisan
Babur, Ozgun
Yun, Kyuson https://orcid.org/0000-0003-2253-4153
Abdelfattah, Nourhan https://orcid.org/0000-0002-0556-0977
Li, Xubin
Bozorgui, Behnaz https://orcid.org/0000-0003-0557-1681
Farach-Carson, Mary C.
Rostomily, Robert C. https://orcid.org/0000-0003-1431-162X
Korkut, Anil https://orcid.org/0000-0001-8072-9026
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (U01CA253472)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA016672)
U.S. Department of Health & Human Services | National Institutes of Health (R01-CA181445)
Article History
Received: 12 December 2024
Accepted: 13 November 2025
First Online: 5 January 2026
Competing interests
: Kyuson Yun is a co-founder of EMPIRI, Inc. Zeynep Dereli is a co-founder of Vivoz Biolabs.